{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:24:00Z","timestamp":1794558240646,"version":"4.9.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00405-026-10542-z","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T21:28:01Z","timestamp":1787174881000},"page":"8071-8077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic stratification using the Aarhus Composite Biomarker Score in recurrent and metastatic head and neck squamous cell carcinoma"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1857-593X","authenticated-orcid":false,"given":"Mustafa","family":"\u015eahbazlar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Melike","family":"D\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferhat","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atike P\u0131nar","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"11","key":"10542_CR1","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","volume":"359","author":"JB Vermorken","year":"2008","unstructured":"Vermorken JB, Mesia R, Rivera F et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359(11):1116\u20131127. https:\/\/doi.org\/10.1056\/NEJMoa0802656","journal-title":"N Engl J Med"},{"key":"10542_CR2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02144","author":"M Tahara","year":"2025","unstructured":"Tahara M, Burtness B, Greil R et al (2025) Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the phase III KEYNOTE-048 study. J Clin Oncol. Epub ahead of print https:\/\/doi.org\/10.1200\/JCO-24-02144","journal-title":"J Clin Oncol"},{"issue":"11","key":"10542_CR3","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC et al (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15(11):e493\u2013e503. https:\/\/doi.org\/10.1016\/S1470-2045(14)70263-3","journal-title":"Lancet Oncol"},{"issue":"5","key":"10542_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"6","key":"10542_CR5","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1016\/S1470-2045(19)30177-9","volume":"20","author":"V Budach","year":"2019","unstructured":"Budach V, Tinhofer I (2019) Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. Lancet Oncol 20(6):e313\u2013e326. https:\/\/doi.org\/10.1016\/S1470-2045(19)30177-9","journal-title":"Lancet Oncol"},{"key":"10542_CR6","doi-asserted-by":"publisher","first-page":"1429559","DOI":"10.3389\/fonc.2024.1429559","volume":"14","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yin X, Wang S et al (2024) Inflammatory markers as prognostic markers in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Oncol 14:1429559. https:\/\/doi.org\/10.3389\/fonc.2024.1429559","journal-title":"Front Oncol"},{"issue":"5","key":"10542_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/hed.25062","volume":"40","author":"MA Mascarella","year":"2018","unstructured":"Mascarella MA, Mannard E, Silva SD et al (2018) Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: a systematic review and meta-analysis. Head Neck 40(5):1091\u20131100. https:\/\/doi.org\/10.1002\/hed.25062","journal-title":"Head Neck"},{"issue":"6","key":"10542_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/bjc.2014.90","volume":"110","author":"CSD Roxburgh","year":"2014","unstructured":"Roxburgh CSD, McMillan DC (2014) Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 110(6):1409\u20131412. https:\/\/doi.org\/10.1038\/bjc.2014.90","journal-title":"Br J Cancer"},{"key":"10542_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2407-13-158","volume":"13","author":"SH Jafri","year":"2013","unstructured":"Jafri SH, Shi R, Mills G (2013) Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer 13:158. https:\/\/doi.org\/10.1186\/1471-2407-13-158","journal-title":"BMC Cancer"},{"key":"10542_CR10","doi-asserted-by":"publisher","first-page":"105188","DOI":"10.1016\/j.oraloncology.2020.105188","volume":"114","author":"P Gaudioso","year":"2021","unstructured":"Gaudioso P, Bonetta A, Carnuccio A et al (2021) Prognostic impact of advanced lung cancer inflammation index in patients with head and neck cancer: a systematic review and meta-analysis. Oral Oncol 114:105188. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.105188","journal-title":"Oral Oncol"},{"issue":"6","key":"10542_CR11","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/j.cllc.2015.03.007","volume":"16","author":"X He","year":"2015","unstructured":"He X, Zhou T, Yang Y et al (2015) Advanced lung cancer inflammation index, a new prognostic score, predicts outcome in patients with small-cell lung cancer. Clin Lung Cancer 16(6):e165\u2013e171. https:\/\/doi.org\/10.1016\/j.cllc.2015.03.007","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"10542_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tranon.2016.05.006","volume":"9","author":"N Aggerholm-Pedersen","year":"2016","unstructured":"Aggerholm-Pedersen N, Maretty-Kongstad K, Keller J et al (2016) The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma. Transl Oncol 9(4):322\u2013328. https:\/\/doi.org\/10.1016\/j.tranon.2016.05.006","journal-title":"Transl Oncol"},{"key":"10542_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12885-021-09108-5","volume":"22","author":"A Winther-Larsen","year":"2022","unstructured":"Winther-Larsen A, Aggerholm-Pedersen N, Sandfeld-Paulsen B et al (2022) Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6210 Danish lung cancer patients. BMC Cancer 22:63. https:\/\/doi.org\/10.1186\/s12885-021-09108-5","journal-title":"BMC Cancer"},{"issue":"1","key":"10542_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41392-020-00419-w","volume":"6","author":"AA Bhat","year":"2021","unstructured":"Bhat AA, Yousuf P, Wani NA et al (2021) Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and resistance to therapy. Signal Transduct Target Ther 6(1):109. https:\/\/doi.org\/10.1038\/s41392-020-00419-w","journal-title":"Signal Transduct Target Ther"},{"key":"10542_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.omto.2021.01.011","volume":"20","author":"Y Qin","year":"2021","unstructured":"Qin Y, Zheng X, Gao W et al (2021) Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma. Mol Ther Oncolytics 20:342\u2013351. https:\/\/doi.org\/10.1016\/j.omto.2021.01.011","journal-title":"Mol Ther Oncolytics"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10542-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10542-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10542-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:07:07Z","timestamp":1794557227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10542-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10542"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10542-z","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Manisa Celal Bayar University Faculty of Medicine (approval number: 20.478.486; approval date: 05\/11\/2025) and conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study, the requirement for informed consent was waived by the institutional ethics committee.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}